Dysplasia in inflammatory bowel diseases.

Area of Science:

• Gastroenterology and Oncology
• Histopathology

Background:

• Colorectal cancer (CRC) prevention in inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, primarily depends on histological identification of dysplasia.
• Dysplasia in IBD signifies a patient subgroup requiring intensified surveillance or prophylactic colectomy.

Purpose of the Study:

• To address current challenges in the histological assessment of dysplasia in inflammatory bowel disease-associated lesions.
• To highlight the importance of accurate dysplasia detection for effective CRC surveillance in IBD patients.

Main Methods:

• Review of current literature and clinical practices regarding dysplasia surveillance in IBD.
• Focus on histological assessment of dysplastic lesions within the context of IBD.

Main Results:

• Despite potential issues such as sampling errors, inconsistent biopsy assessments, and organizational factors, dysplasia surveillance has proven effective.
• Effective surveillance significantly reduces CRC-related mortality and morbidity in IBD patients.

Conclusions:

• Histological assessment of dysplasia remains a cornerstone for secondary CRC prevention in IBD.
• Addressing practical challenges in surveillance is crucial for maximizing its benefits in managing IBD patients at risk for CRC.